Vitamin d and human pregnancy

Fetal and Maternal Medicine Review

Volumn 22, Issue 1, 2011, Pages 67-90

  Grayson, Rebekah ^a   Hewison, Martin ^b  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; PLACENTA LACTOGEN; VITAMIN D;

ASTHMA; AUTISM; BONE MINERALIZATION; CALCIUM ABSORPTION; CHORIOAMNIONITIS; DECIDUA; DISEASE TRANSMISSION; EMBRYO TRANSFER; FERTILIZATION IN VITRO; FETUS DEVELOPMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPOCALCEMIA; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTRAUTERINE INFECTION; KIDNEY INFECTION; MALARIA; MULTIPLE SCLEROSIS; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PLACENTA; PLACENTAL TRANSFER; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PREMATURITY; PROTEIN EXPRESSION; REVIEW; SECONDARY HYPERPARATHYROIDISM; SPONTANEOUS ABORTION; TYPHOID FEVER; VITAMIN D DEFICIENCY;

EID: 83055168737     PISSN: 09655395     EISSN: 14695065     Source Type: Journal    
DOI: 10.1017/S0965539511000039     Document Type: Review

References (223)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
2. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009; 19: 73-78.
3. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997; 7: 439-43.
4. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003; 22: 142-46.
5. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713-16.
6. Mithal A,Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009; 20: 1807-20.
7. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995; 61: 638S-45S.
8. Pal BR, Marshall T, James C, Shaw NJ. Distribution analysis of vitamin D highlights differences in population subgroups: preliminary observations from a pilot study in UK adults. J Endocrinol 2003; 179: 119-29.
9. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477-501.
10. Johnson DD, Wagner CL, Hulsey TC, McNeil RB, Ebeling M, Hollis BW. Vitamin D Deficiency and Insufficiency is Common during Pregnancy. Am J Perinatol 2011; 1: 7-12.
11. Bodnar LM, Simhan HN, Powers RW, Frank MP, Cooperstein E, Roberts JM. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 2007; 137: 447-52.
12. Spina CS, Tangpricha V, Uskokovic M, Adorinic L, Maehr H, Holick MF. Vitamin D and cancer. Anticancer Res 2006; 26: 2515-24.
13. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006; 92: 39-48.
14. Hewison M. Vitamin D and innate immunity. Curr Opin Investig Drugs 2008; 9: 485-90.
15. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008; 4: 80-90.
16. Omdahl JL, Bobrovnikova EA, Choe S, Dwivedi PP, May BK. Overview of regulatory cytochrome P450 enzymes of the vitamin D pathway. Steroids 2001; 66: 381-89.
17. White P, Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000; 11: 320-327.
18. Laing JCN. Vitamin D-binding protein. In: Feldman D, Pike JW, Glorieux FH, (eds). Vitamin D. Amersterdam, Elsevier 2005; 117-52.
19. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999; 96: 507-15.
20. Omdahl JL, Morris HA, May BK. Hydroxylase enzymes of the vitamin D pathway: expression, function, and regulation. Annu Rev Nutr 2002; 22: 139-66.
21. Jurutka PW, Bartik L, Whitfield GK, Mathern DR, Barthel TK, Gurevich M, et al. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J Bone Miner Res 2007; 22 Suppl 2: V2-10.
22. Juppner H, Wolf M, Salusky IB. FGF23: more than a regulator of renal phosphate handling? J Bone Miner Res 2010; 10: 2091-2097.
23. Adams JS, Gacad MA. Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J ExpMed 1985; 161: 755-65.
24. Papapoulos SE, Clemens TL, Fraher LJ, Lewin IG, Sandler LM, O'Riordan JL. 1, 25- dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet 1979; 1: 627-30.
25. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86: 888-94.
26. Gray TK, Lester GE, Lorenc RS. Evidence for extra-renal 1 alpha-hydroxylation of 25-hydroxyvitamin D3 in pregnancy. Science 1979; 204: 1311-313.
27. Weisman Y, Harell A, Edelstein S, David M, Spirer Z, Golander A. 1 alpha, 25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature 1979; 281: 317-19.
28. Zehnder D, Evans KN, Kilby MD, Bulmer JN, Innes BA, Stewart PM, et al. The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am J Pathol 2002; 161: 105-14.
29. Evans KN, Bulmer JN, Kilby MD, Hewison M. Vitamin D and placental-decidual function. J Soc Gynecol Investig 2004; 11: 263-71.
30. Vanhooke JL, Prahl JM, Kimmel-Jehan C,Mendelsohn M, Danielson EW, Healy KD, et al. CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1{alpha}-hydroxylase promoter activity in the skin. Proc Natl Acad Sci U S A. 2006; 103: 75-80.
31. Sakaki T, Kagawa N, Yamamoto K, Inouye K. Metabolism of vitamin D3 by cytochromes P450. Front Biosci 2005; 10: 119-34.
32. Novakovic B, Sibson M, Ng HK, Manuelpillai U, Rakyan V, Down T, et al. Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem 2009; 284: 14838-848.
33. Kovac C. Vitamin D in pregnancy and lactation: maternal, fetal and neonatal outcomes from human and animal studies. Am J Clin Nutr 2008; 88(suppl): 520S-8S.
34. Care A. The placental transfer of calcium. J Dev Physiol 1991; 15: 253-57.
35. Locatelli A, Patane L, Ghidini A, Marinetti E, Zagarella A, Pezzullo JC, et al. Pathology findings in preterm placentas of women with autoantibodies: a case-control study. J Matern Fetal Neonatal Med 2002; 11: 339-44.
36. Givens M, Taylor R, Kitzmiller J. The chemical composition of the human fetus. J Biol Chem 1993; 102: 7-17.
37. David L, Anast C. Calicium metabolism in newborn infants. The interrelationship of parathyroid function and calcium, magnesium, and phosphorous metabolim in normal, sick and hypocalcemic newborns. J Clin Invest 1974; 54: 287-96.
38. MacIsaac R, Heath J, Rodda C, Moseley J, Care A, Martin T, et al. Role the fetal pararthyroid glands and parathyroid hormone-related protein in the regulation of placental transport of calcium, magnesium and inorganic phosphate. Reprod Fertil Dev 1991; 3: 447-57.
39. Math F, Davrainville J. Postnatal variations of extracelluar free calcium levels in the rat. Influence of under nutrition. Experientia 1979; 35: 1355-356.
40. Lima M, Kallfelz F, Krook L, Nathanielsz P. Humeral skeletal development and plasma constituent changes in foetuses of ewes maintained on a low calcium diet from 60 days gestation. Calcif Tissue Int 1993; 52: 283-90.
41. Fisher G, Kelly L, Smith C. ATP-dependant calcium transport across basal plasma membranes of human placental trophoblast. Am J Physiol 1987; 252: C38-C46.
42. Borke J, Caride A, Verma A, Kelly L, Smith C, Penniston J, et al. Calicum pump epitopes in placental trophoblast basal plasma membranes. Am J Physiol 1989; 257: C38-C46.
43. Cross N, Hillman L, Allen S, Krause G, Vieira N. Calcium homeostasis and bone metabolism during pregnancy, lactation and postweaning: a longitudinal study. Am J Clin Nutr 1995; 61: 514-23.
44. Heaney R, Skillman T. Calcium metabolism in normal human pregnancy. J Clin Endocrinol Metab 1971; 33: 277-82.
45. Kent G, Price R, Gutteridge D, Rosman K, Smith M, Allen J, et al. The efficiency of intestinal calcium absorption is increased in late pregnancy but not in established lactation. Calif Tissue Int 1991; 48: 293-95.
46. Gertner J, Coustan D, Kliger A, Mallette L, Ravin N, Broadus A. Pregnancy as state of physiologic absorptive hypercalciuria. Am J Med 1986; 81: 451-56.
47. Kent G, Price R, Gutteridge D, Allen J, Blakeman S, Bhagat C, et al. Acute effects of an oral calcium load in pregnancy and lactation: findings on renal calcium conservation and biochemical indices of bone turnover. Miner Electrolute Metab 1991; 17: 1-7.
48. Hillman L, Slatopolsky E, Haddad J. Perinatal vitamin D metabolism. IV. Maternal and cord serum 24,25-dihydroxyvitamin D concentrations. J Clin Endocrinol Metab 1978; 47: 1073-77.
49. Mahmud N, Molloy A,McPartlin J, Corbally R, Whitehead AS, Scott JM, et al. Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 1999; 45: 389-94.
50. Wieland P, Fischer J, Trechsel U, Roth H, Vetter K, Schneider H, et al. Perinatal parathyroid hormone, vitamin D metabolites, and calcitonin in man. Am J Physiol 1980; 239: E385-E90.
51. Lund B, Selnes A. Plasma 1,25-dihydroxyvitaminDlevels in pregnancy and lactation. Acta Endocrinol (Copenh) 1979; 92: 330-35.
52. Bikle DD, Gee E, Halloran B, Haddad JG. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 1984; 74: 1966-71.
53. Wilson S, Retallack R, Kent J,Worth G, Gutteridge D. Serum free 1,25-dihydroxyvitamin D and the free 1,25-dihydroxyvitamin D index during a longitudinal study of human pregnancy and lactation. Clin Endocrinol (Oxf) 1990; 32: 613-22
54. Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 1997; 18: 832-72.
55. Kovacs C. Calcium and bone metabolism in pregnancy and lactation. J Clin Endorinol Metab 2001; 86: 2344-348.
56. Gray TK, Lowe W, Lester GE. Vitamin D and pregnancy: the maternal-fetal metabolism of vitamin D. Endocr Rev 1981; 2: 264-74.
57. Weisman Y, Vargas A, Duckett G, Reiter E, Root A. Synthesis of 1,25-dihydroxyvitamin D in the nephrectomized pregnant rat. Endocrinology 1978; 103: 1992-996.
58. Castillo L, Tanaka Y, Wineland MJ, Jowsey JO, DeLuca HF. Production of 1,25-dihydroxyvitamin D3 and formation of medullary bone in the egg-laying hen. Endocrinology 1979; 104: 1598-601.
59. Weisman Y, Sapir R, Harell A, Edelstein S. Maternal-perinatal interrelationships of vitamin D metabolism in rats. Biochim Biophys Acta 1976; 428: 388-95.
60. Glorieux F, Arabian A, Delvin E. Pseudo-vitamin D deficiency:absence of 25-hydroxyvitamin D 1 alpha-hydroxylase activityin human placenta decidual cells. J Clin Endocrinol Metab 1995; 80: 2255-258.
61. Weisman Y, Vargas A, Duckett G, Reiter E, Root A. Synthesis of 1,25-dihydroxyvitamin D in the nephrectomized pregnant rat. Endocrinology 1978; 103: 1992-996.
62. Lachenmaier-Currle U, Harmeyer J. Placental transport of calcium and phosphorus in pigs. J Perinat Med 1989; 17: 127-36.
63. Paulson S, Ford K, Langman C. Pregnancy does not alter the metabolic clearance of 1,25- dihydroxyvitamin D in rats. Am J Physiol 1990; 258: E158-E62.
64. Delvin E, Gilbert M, Pere M, Garel J. In vivo metabolism of calcitriol in the pregnant rabbit doe. J Dev Physiol 1988; 10: 451-59.
65. Ross R, Halbert K, Tsang R. Determination of the production and metabolic clearance rates of 1,25- dihydroxyvitamin D3 in the pregnant sheep and its chronically catheterized fetus by primed infusion technique. Pediatr Res 1989; 26: 633-38.
66. Dahlman T, Sjoberg H, Bucht E. Calcium homeostasis in normal pregnancy and puerperium. A longitudinal study. Acta Obstet Gynecol Scand 1994; 73: 393-98.
67. Seki K, Makimura N, Mitsui C, Hirata J, Nagata I. Calcium regulating hormones and osteocalcin levels during pregnancy: a longitudinal study. Am J Obstet Gynecol 1991; 164: 1248-52.
68. Rasmussen N, Frolich A, Hornnes P, Hegedus L. Serum ionized calcium and intact parathyroid hormone levels during pregnancy and postpartum. Br J Obstet Gynaecol 1990; 97: 857-59.
69. Gallacher S, Fraser W, Owens O, Dryburgh F, Logue F, Jenkins A, et al. Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancy. Eur J Endocrinol 1994; 131: 369-74.
70. Baksi S, Kenny A. Acute effect of estradiol on the renalvitamin D hydroxylases in Japanese quail. Biochem Pharmacol 1978; 27: 2765-768.
71. Spanos E, Colston K, Evans I, Galante L, Macauley S, MacIntyre I. Effect of prolactin on vitamin D metabolism. Mol Cell Endocrinol 1979; 5: 163-67
72. Spanos E, Brown D, Stevenson J, MacIntyre I. Stimulation of 1,25-dihydroxycholecalciferol production by prolactin and related peptides in intact renal cell preparations in vitro. Biochim Biophys Acta 1981; 672: 7-15
73. Noff D, Edelstein S. Vitamin D and its hydroxylated metabolites in the rat. Placental and lacteal transport, subsequent metabolic pathways and tissue distribution. Horm Res 1978; 9: 292-300.
74. Ross R, Care A, Robinson J, Pickard D, Weatherley A. Perinatal 1,25-dihydroxycholecalciferol in the sheep and its role in the maintenance of the transplacental calcium gradient. J Endocrinol 1980; 87: 17P-8P.
75. Whitfield GK, Dang HT, Schluter SF, Bernstein RM, Bunag T, Manzon LA, et al. Cloning of a functional vitamin D receptor from the lamprey (Petromyzon marinus), an ancient vertebrate lacking a calcified skeleton and teeth. Endocrinology 2003; 144: 2704-716.
76. Fleischman A, Rosen J, Cole J, Smith C, DeLuca H.Maternal and fetal serum 1,25-dihydroxyvitamin D levels at term. J Pediatr 1980; 97: 640-42.
77. Seki K, Furuya K, Makimura N, Mitsui C, Hirata J, Nagata I. Cord blood levels of calcium-regulating hormones and osteocalcinin premature infants. J Perinat Med 1994; 22: 189-94.
78. Hollis B, Pittard W. Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences. J Clin Endocrinol Metab 1984; 59: 652-57.
79. Haddad JG, Jr., Boisseau V, Avioli LV. Placental transfer of vitamin D3 and 25-hydroxycholecalciferol in the rat. J Lab Clin Med 1971; 77: 908-15.
80. Brommage R, DeLuca H. Placental transport of calcium and phosphorus is not regulated by vitamin D. Am J Physiol 1984; 246: F526-F9.
81. Halloran B, De Luca H. Effect of vitamin D deficiency on skeletal development during early growth in the rat. Arch Biochem Biophys 1981; 209: 7-14.
82. Miller S,Halloran B,DeLuca H, Jee W. Studies on the role of vitaminDin early skeletal development, mineralization, and growth in rats. Calcif Tissue Int 1983; 35: 455-60.
83. Yoshizawa T, Handa Y, Uematsu Y, Sekine K, Takeda S, Yoshihara Y, et al. Disruption of the vitamin D receptor (VDR) in the mouse [abstract]. J Bone Miner Res 1996; 11 (Suppl 1): S124.
84. Li Y, Pirro A, Amling M, Delling G, Baron R, Bronson R, et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D dependent rickets type II with alopecia. Proc Natl Acad Sci USA 1997; 94: 9831-835.
85. Glazier J, Mawer E, Sibley C. Calbindin-D9K gene expression in rat chorioallantoic placenta is not regulated by 1,25-dihydroxyvitamin D3. Pediatr Res 1995; 37: 720-25.
86. Campbell D, Fleischman A. Rickets of prematurity: controversies in causation and prevention. Clin Perinatol 1988; 15: 879-90.
87. Specker B. Do North American women need supplemental vitamin D during pregnancy or lactation?. Am J Clin Nutr 1994; (59 Suppl): 484S-90S.
88. Shamley D, Veale G, Pettifor J, Buffenstein R. Trophoblastic giant cells of the mouse placenta contain calbindin-D9K but not the vitamin D receptor. J Endocrinol 1996; 150: 25-32.
89. Tanamura A, Nomura S, Kurauchi O, Furui T, Mizutani S, Tomoda Y. Purification and characterization of 1,25(OH)2D3 receptor from human placenta. J Obstet Gynaecol 1995; 21: 631-39.
90. Stumpf W, Sar M, Narbaitz R, Huang S, DeLuca H. Autoradiographic localization of 1,25- dihydroxyvitamin D3 in rat placenta and yolk sac. Horm Res 1983; 18: 215-20.
91. Durand D, Barlet J, Braithwaite G. The influence of 1,25- dihydroxycholecalciferol on the mineral content of foetal guinea pigs. Reprod Nutr Dev 1983; 23: 235-44.
92. Durand D, Braithwaite G, Barlet J. The effect of 1a- hydroxycholecalciferol on the placental transfer of calcium and phosphate in sheep. Br J Nutr 1983; 49: 475-80.
93. Leroyer-Alizon E, David L, Anast C, Dubois P. Immunocytological evidence for parathyroid hormone in human fetal parathyroid glands. J Clin Endocrinol Metab 1981; 52: 513-16.
94. Weatherley A, Ross R, Pickard D, Care A. The transfer of calcium during perfusion of the placenta and intact and thyroparathyroidectomized sheep. Placenta 1983; 4: 271-77.
95. Gensure RC, Gardella TJ, Juppner H. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun 2005; 328: 666-78.
96. Loveridge N, Dean V, Goltzman D, Hendy GN. Bioactivity of parathyroid hormone and parathyroid hormone-like peptide: agonist and antagonist activities of amino-terminal fragments as assessed by the cytochemical bioassay and in situ biochemistry. Endocrinology 1991; 128: 1938-46.
97. Fenton SL, Drayson MT, Hewison M, Vickers E, Brown G, Bunce CM. Clofibric acid: a potential therapeutic agent in AML and MDS. Br J Haematol 1999; 105: 448-51.
98. Cornish J, Callon K, Nicholson G, Reid I. Parathyroid hormone-related protein-(107-139) inhibits bone resorption in vivo. Endocrinology 1997; 138: 1299-304.
99. Seki K, Wada S, Nagata N, Nagata I. Parathyroid hormone related protein during pregnancy and the perinatal period. Gynecol Obstet Invest 1994; 37: 83-86.
100. MacIsaac R, Caple I,Danks J, Diefenbach-Jagger H, Grill V, Moseley J, et al. Ontogeny of parathyroid hormone-related protein in the ovine parathyroid gland. Endocrinology 1991; 129: 757-64.
101. Abbas S, Pickard D, Illingworth D, Storer J, Purdie D, Moniz C, et al. Measurement of parathyroid hormone-related protein in extracts of fetal parathyroid glands and placentalmembranes. J Endocrinol 1990; 24: 319-25.
102. Lee K,Deeds J, Segre G. Expression of parathyroid hormone- related peptide and its receptormessenger ribonucleic acids during fetal development of rats. Endocrinology 1995; 136: 453-63.
103. Karmali R, Schiffmann S, Vanderwinden J, Hendy G, Nys-DeWolf N, Corvilain J, et al. Expression of mRNA of parathyroid hormone-related peptide in fetal bones of the rat. Cell Tissue Res 1992; 270: 597-600.
104. Senior P, Heath D, Beck F. Expression of parathyroid hormone-related protein mRNA in the rat before birth: demonstration by hybridization histochemistry. J Mol Endocrinol 1991; 6: 281-90.
105. Bowden S, Emly J, Hughes S, Powell G, Ahmed A, Whittle M, et al. Parathyroid hormone-related protein in human term placenta and membranes. J Endocrinol 1994; 142: 217-24.
106. Esber EJ, Ferguson DR. Primary sclerosing cholangitis. Gastroenterologist 1994; 2: 131-46.
107. Wasserman RH, Smith CA, Brindak ME, De Talamoni N, Fullmer CS, Penniston JT, et al. VitaminDand mineral deficiencies increase the plasma membrane calcium pump of chicken intestine. Gastroenterology. 1992; 102: 886-94.
108. Miller S, Halloran B, DeLuca H, Jee W. Role of vitamin D in maternal skeletal changes during pregnancy and lactation: a histomorphometric study. Calcif Tissue Int 1982; 34: 245-52.
109. Bruns ME, Bruns DE. Vitamin D metabolism and function during pregnancy and the neonatal period. Ann Clin Lab Sci 1983; 13: 521-30.
110. Rebut-Bonneton C, Demignon J. Effects of 1,25-dihydroxyvitamin D3 on in vitro lymphocyte reactions: arguments for a role at the maternofetal interface. Gynecol Obstet Invest 1991; 32: 134-38.
111. Sacks G, Sargent I, Redman C. Innate immunity in pregnancy. Immunol Today 2000; 21: 200-201.
112. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today. 1999; 20: 114-18.
113. Guleria I, Pollard JW. The trophoblast is a component of the innate immune system during pregnancy. Nat Med 2000; 6: 589-93.
114. Zenclussen AC, Schumacher A, Zenclussen ML, Wafula P, Volk HD. Immunology of pregnancy: cellular mechanisms allowing fetal survival within the maternal uterus. Expert Rev Mol Med 2007; 9: 1-14.
115. Laskarin G, Kammerer U, Rukavina D, Thomson AW, Fernandez N, Blois SM. Antigen-presenting cells and materno-fetal tolerance: an emerging role for dendritic cells. Am J Reprod Immunol 2007; 58: 255-67.
116. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998; 78: 1193-231.
117. Townsend K, Evans KN, Campbell MJ, Colston KW, Adams JS, Hewison M. Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 2005; 97: 103-109.
118. Adams JS, Liu P, Chun R, Modlin RL, Hewison M. Vitamin D in Defense of the Human Immune Response. Ann N Y Acad Sci 2007; 1117: 94-105
119. Mathieu C, van Etten E, Decallonne B, Guilietti A, Gysemans C, Bouillon R, et al. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol 2004; 89-90: 449-52.
120. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004; 80(6 Suppl): 1717S-20S.
121. Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr 2003; 23: 117-45.
122. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. Faseb J 2001; 15: 2579-85.
123. Campbell MJ, Adorini L. The vitamin D receptor as a therapeutic target. Expert Opin Ther Targets 2006; 10: 735-48.
124. Hewison M, Zehnder D, Chakraverty R, Adams JS. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol 2004; 215: 31-38.
125. Kreutz M, Andreesen R, Krause SW, Szabo A, Ritz E, Reichel H. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 1993; 82: 1300-1307.
126. Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, et al.Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003; 170: 5382-390.
127. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167: 4974-80.
128. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25- dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995; 125 (6 Suppl): 1704S- 8S.
129. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J ExpMed 2002; 195: 603-16.
130. Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, et al. DCs metabolize sunlightinduced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007; 8: 285-93.
131. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-773.
132. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004; 75: 39-48.
133. Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36: 361-70.
134. Wang TT, Dabbas B, Laperriere D, Bitton AJ, Soualhine H, Tavera-Mendoza LE, et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem. Jan 22; 285: 2227-31.
135. Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, Kim KK, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009; 6: 231-43.
136. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, et al. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 2009; 182: 4289-295.
137. Chun RF, Lauridsen AL, Suon L, Zella LA, Pike JW, Modlin RL, et al. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab 2010; 95: 3368-76.
138. Wang TT, Nestel FP, Bourdeau V, Nagai Y,Wang Q, Liao J, et al.Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173: 2909-12.
139. Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Kiken D, et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 2007; 117: 803-11.
140. Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y, et al. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 2010; 151: 2423-432.
141. Liu N, Nguyen L, Chun RF, Lagishetty V, Ren S, Wu S, et al. Altered endocrine and autocrine metabolism of vitamin d in a mouse model of gastrointestinal inflammation. Endocrinology 2008; 149: 4799-808.
142. Vigano P, Mangioni S, Pompei F, Chiodo I. Maternal-conceptus cross talk-a review. Placenta 2003; 24 Suppl B: S56-61.
143. Chambon Y. Synergic action of vitamin D and of progesterone in obtaining ovum implantation in the castrated pregnant rabbit. C R Seances Soc Biol Fil 1951; 145: 955-59.
144. Zane CE. Assessment of Hypervitaminosis D during the first trimester of pregnancy on the mouse embryo. Preliminary report. Arzneimittelforschung. 1976; 26: 1589-590.
145. Halhali A, Acker GM, Garabedian M. 1,25-Dihydroxyvitamin D3 induces in vivo the decidualization of rat endometrial cells. J Reprod Fertil 1991; 91: 59-64.
146. Salamonsen LA, Nie G, Findlay JK. Newly identified endometrial genes of importance for implantation. J Reprod Immunol 2002; 53: 215-25.
147. Luu KC, Nie GY, Hampton A, Fu GQ, Liu YX, Salamonsen LA. Endometrial expression of calbindin (CaBP)-d28k but not CaBP-d9k in primates implies evolutionary changes and functional redundancy of calbindins at implantation. Reproduction 2004; 128: 433-41.
148. Du H, Daftary GS, Lalwani SI, Taylor HS. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol Endocrinol 2005; 19: 2222-2233.
149. Bubanovic I. 1alpha,25-dihydroxy-vitamin-D3 as new immunotherapy in treatment of recurrent spontaneous abortion. Med Hypotheses 2004; 63: 250-53.
150. Ozkan S, Jindal S, Greenseid K, Shu J, Zeitlian G, Hickmon C, et al. Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil Steril 2010; 94: 1314-319.
151. King AE, Kelly RW, Sallenave JM, Bocking AD, Challis JR. Innate immune defences in the human uterus during pregnancy. Placenta 2007; 28: 1099-106.
152. King AE, Paltoo A, Kelly RW, Sallenave JM, Bocking AD, Challis JR. Expression of natural antimicrobials by human placenta and fetal membranes. Placenta 2007; 28: 161-69.
153. Svinarich DM, Wolf NA, Gomez R, Gonik B, Romero R. Detection of human defensin 5 in reproductive tissues. Am J Obstet Gynecol 1997; 176: 470-75.
154. Abrahams VM, Schaefer TM, Fahey JV, Visintin I, Wright JA, Aldo PB, et al. Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I: C). Hum Reprod 2006; 21: 2432-439.
155. Evans KN, Nguyen L, Chan J, Innes BA, Bulmer JN, Kilby MD, et al. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod 2006; 75: 816-22.
156. Liu N, Kaplan AT, Low J, Nguyen L, Liu GY, Equils O, et al. Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol Reprod 2009; 80: 398-406.
157. Bodnar LM, Krohn MA, Simhan HN. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr 2009; 139: 1157-61.
158. Mehta S, Hunter DJ, Mugusi FM, Spiegelman D, Manji KP, Giovannucci EL, et al. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis 2009; 200: 1022-30.
159. Al-Husaini AM. Role of placenta in the vertical transmission of human immunodeficiency virus. J Perinatol 2009; 29: 331-36.
160. Coid CR, Sandison H, Slavin S, Altman DG. Escherichia coli infection in mice and impaired fetal development. Br J Exp Pathol 1978; 59: 292-97.
161. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371: 75-84.
162. Vergnes JN, Sixou M. Preterm low birth weight and maternal periodontal status: a meta-analysis. Am J Obstet Gynecol 2007; 196: 135 e1-7. 163.
163. Dudley DJ. Pre-term labor: an intra-uterine inflammatory response syndrome? J Reprod Immunol 1997; 36: 93-109.
164. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007; 25: 21-39.
165. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel LA, Nien JK. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 2006; 11: 317-26.
166. Romero R, Erez O, Espinoza J. Intrauterine infection, preterm labor, and cytokines. J Soc Gynecol Investig 2005; 12: 463-5.
167. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993; 81: 941-48.
168. Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M, et al. Diagnosis of intraamniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004; 292: 462-69.
169. El-Shazly S, Makhseed M, Azizieh F, Raghupathy R. Increased expression of pro-inflammatory cytokines in placentas of women undergoing spontaneous preterm delivery or premature rupture of membranes. Am J Reprod Immunol 2004; 52: 45-52.
170. Blank V,Hirsch E,Challis JR, Romero R, Lye SJ.Cytokine Signaling, Inflammation, Innate Immunity and Preterm Labour. Placenta 2008; 29 Suppl A: S102-4.
171. Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997; 11: 135-76.
172. Ogunyemi D, Murillo M, Jackson U, Hunter N, Alperson B. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonat Med 2003; 13: 102-109.
173. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988; 319: 972-78.
174. Zlatnik FJ, Gellhaus TM, Benda JA, Koontz FP, Burmeister LF. Histologic chorioamnionitis, microbial infection, and prematurity. Obstet Gynecol 1990; 76: 355-59.
175. Lahra MM, Jeffery HE. A fetal response to chorioamnionitis is associated with early survival after preterm birth. Am J Obstet Gynecol 2004; 190: 147-51.
176. Diaz L, Noyola-Martinez N, Barrera D, Hernandez G, Avila E, Halhali A, et al. Calcitriol inhibits TNF-alpha-induced inflammatory cytokines in human trophoblasts. J Reprod Immunol 2009; 81: 17-24.
177. Norman AW, Bouillon R, Whiting SJ, Vieth R, Lips P. 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 2007; 103: 204-205.
178. Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002; 76: 187-92.
179. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007; 92: 3517-22
180. Hollis BW, Wagner CL. Vitamin D deficiency during pregnancy: an ongoing epidemic. Am J Clin Nutr 2006; 84: 273.
181. Hollis BW, Wagner CL. Nutritional vitamin D status during pregnancy: reasons for concern. CMAJ 2006; 174: 1287-290.
182. Hollis BW,Wagner CL.Assessment of dietary vitaminDrequirements during pregnancy and lactation. Am J Clin Nutr 2004; 79: 717-26.
183. Ginde AA, Sullivan AF Mansbach JM Camargo CA Jr. Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States. Am J Obstet Gynecol 2010; 202: 436 e1-8.
184. Newhook LA, Sloka S, Grant M, Randell E, Kovacs CS, Twells LK. Vitamin D insufficiency common in newborns, children and pregnant women living in Newfoundland and Labrador, Canada. Matern Child Nutr 2009; 5: 186-91.
185. Sloka S, Stokes J, Randell E, Newhook LA. Seasonal variation of maternal serum vitamin D in Newfoundland and Labrador. J Obstet Gynaecol Can 2009; 31: 313-21.
186. Holmes VA, Barnes MS, Alexander HD, McFaul P, Wallace JM. Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study. Br J Nutr 2009; 102: 876-81.
187. Bowyer L, Catling-Paull C, Diamond T, Homer C, Davis G, Craig ME. Vitamin D, PTH and calcium levels in pregnant women and their neonates. Clin Endocrinol (Oxf). 2009; 70: 372-77.
188. O'Riordan MN, Kiely M, Higgins JR, Cashman KD. Prevalence of suboptimal vitamin D status during pregnancy. Ir Med J 2008; 101: 240, 242-433.
189. Madar AA, Stene LC, Meyer HE. Vitamin D status among immigrant mothers from Pakistan, Turkey and Somalia and their infants attending child health clinics in Norway. Br J Nutr 2009; 101: 1052-58.
190. Farrant HJ, Krishnaveni GV, Hill JC, Boucher BJ, Fisher DJ, Noonan K, et al. VitaminDinsufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size. Eur J Clin Nutr 2009; 63: 646-52.
191. Kazemi A, Sharifi F, Jafari N, Mousavinasab N. High prevalence of vitamin D deficiency among pregnant women and their newborns in an Iranian population. J Womens Health (Larchmt). 2009; 18: 835-39.
192. Salek M, Hashemipour M, Aminorroaya A, Gheiratmand A, Kelishadi R, Ardestani PM, et al. VitaminDdeficiency among pregnantwomen and their newborns in Isfahan, Iran. ExpClin Endocrinol Diabetes 2008; 116: 352-56.
193. Narchi H, Kochiyil J, Zayed R, Abdulrazzak W, Agarwal M. Maternal vitamin D status throughout and after pregnancy. J Obstet Gynaecol 2010; 30: 137-342.
194. Teale GR, Cunningham CE. Vitamin D deficiency is common among pregnant women in rural Victoria. Aust N Z J Obstet Gynaecol 2010; 50: 259-61.
195. Davis LM, Chang SC, Mancini J, Nathanson MS, Witter FR, O'Brien KO. Vitamin D insufficiency is prevalent among pregnant African American adolescents. J Pediatr Adolesc Gynecol 2010; 23: 45-52.
196. Mahon P, Harvey N, Crozier S, Inskip H, Robinson S, Arden N, Swaminathan R, Cooper C, Godfrey K. Low maternal vitamin D status and fetal bone development: cohort study. J Bone Miner Res 2010; 25: 14-19.
197. Javaid MK, Crozier SR, Harvey NC, Gale CR, Dennison EM, Boucher BJ, et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 2006; 367: 36-43.
198. Robinson CJ, Alanis MC, Wagner CL, Hollis BW, Johnson DD. Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia. Am J Obstet Gynecol 2010; 203: 366. e1-6.
199. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007; 92: 3517-22.
200. Diaz L, Arranz C, Avila E, Halhali A, Vilchis F, Larrea F. Expression and activity of 25- hydroxyvitamin D-1 alpha-hydroxylase are restricted in cultures of human syncytiotrophoblast cells from preeclamptic pregnancies. J Clin Endocrinol Metab 2002; 87: 3876-882.
201. Haugen M, Brantsaeter AL, Trogstad L, Alexander J, Roth C, Magnus P, et al. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology 2009; 20: 720-26.
202. Cooper C,Westlake S, Harvey N, Javaid K, Dennison E, Hanson M. Review: developmental origins of osteoporotic fracture. Osteoporos Int 2006; 17: 337-47.
203. O'Loan J, Eyles DW, Kesby J, Ko P, McGrath JJ, Burne TH. Vitamin D deficiency during various stages of pregnancy in the rat; its impact on development and behaviour in adult offspring. Psychoneuroendocrinology 2007; 32: 227-34.
204. Eyles DW, Feron F, Cui X, Kesby JP, Harms LH, Ko P, et al. Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology 2009; 34 Suppl 1: S247-57.
205. Mackay-Sim A, Feron F, Eyles D, Burne T, McGrath J. Schizophrenia, vitamin D, and brain development. Int Rev Neurobiol 2004; 59: 351-80.
206. Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience 2003; 118: 641-53.
207. McGrath JJ, Burne TH, Feron F, Mackay-Sim A, Eyles DW. Developmental vitamin D deficiency and risk of schizophrenia: A 10-Year Update. Schizophr Bull 2010; 36: 1073-78.
208. Marjamaki L, Niinisto S, Kenward MG, Uusitalo L, Uusitalo U, Ovaskainen ML, et al. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 2010; 53: 1599-607.
209. Zhang C, Qiu C, Hu FB, David RM, van Dam RM, Bralley A, et al. Maternal plasma 25- hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS One 2008; 3: e3753.
210. Salzer J, Svenningsson A, Sundstrom P. Season of birth and multiple sclerosis in Sweden. Acta Neurol Scand 2010; 122: 70-73.
211. Gale CR, Robinson SM, Harvey NC, Javaid MK, Jiang B, Martyn CN, et al. Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr 2008; 62: 68-77.
212. Camargo CA, Jr., Rifas-Shiman SL, Litonjua AA, Rich-Edwards JW, Weiss ST, Gold DR, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr 2007; 85: 788-95.
213. Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol 2007; 120: 1031-1035.
214. Clifton-Bligh RJ, McElduff P, McElduff A. Maternal vitamin D deficiency, ethnicity and gestational diabetes. Diabet Med 2008; 25: 678-84.
215. Ramos-Lopez E, Kahles H,Weber S, Kukic A, Penna-MartinezM, Louwen F, et al. Gestational diabetes mellitus and vitamin D deficiency: genetic contribution of CYP27B1 and CYP2R1 polymorphisms. Diabetes Obes Metab 2008; 10:683-85.
216. Bodnar LM, Catov JM, Zmuda JM, Cooper ME, Parrott MS, Roberts JM, et al. Maternal serum 25- hydroxyvitaminDconcentrations are associated with small-for-gestational age births in whitewomen. J Nutr 2010; 140: 999-1006.
217. Leffelaar ER, Vrijkotte TG, van Eijsden M. Maternal early pregnancy vitamin D status in relation to fetal and neonatal growth: results of the multi-ethnic Amsterdam Born Children and their Development cohort. Br J Nutr 2010; 104: 108-17.
218. Mahon P, Harvey N, Crozier S, Inskip H, Robinson S, Arden N, et al. Low maternal vitamin D status and fetal bone development: cohort study. J Bone Miner Res 2010; 25: 14-9.
219. Viljakainen HT, Saarnio E, Hytinantti T, Miettinen M, Surcel H, Makitie O, et al. Maternal vitamin D status determines bone variables in the newborn. J Clin Endocrinol Metab 2010; 95: 1749-57.
220. Raiten DJ, Picciano MF. Vitamin D and health in the 21st century: bone and beyond. Executive summary. Am J Clin Nutr 2004; 80(6 Suppl): 1673S-7S.
221. Cole ZA, Gale CR, Javaid MK, Robinson SM, Law C, Boucher BJ, et al. Maternal dietary patterns during pregnancy and childhood bone mass: a longitudinal study. J Bone Miner Res 2009; 24: 663-68.
222. Weiss ST, Litonjua AA. Childhood asthma is a fat-soluble vitamin deficiency disease. Clin Exp Allergy 2008; 38: 385-87.
223. GrantWB, Soles CM. Epidemiologic evidence supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism. Dermatoendocrinol 2009; 1: 223-28.